Showing results (161-170 of 201) with videos related to
Sort By:
Pageof 21
British Journal of Pharmacology|October 17, 1998
SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activityJ V Selkirk, C Scott, M Ho, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|September 26, 1997
SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptorsG W Price, M J Burton, L J Collin, et al.British Journal of Pharmacology|May 12, 2000
[(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptorsD R Thomas, P J Atkinson, M Ho, et al.Cell Death and Differentiation|January 13, 2009
GAP-43 is essential for the neurotrophic effects of BDNF and positive AMPA receptor modulator S18986S K Gupta, R Mishra, S Kusum, et al.British Journal of Pharmacology|August 1, 1995
Neuroprotective properties of lifarizine compared with those of other agents in a mouse model of focal cerebral ischaemiaC M Brown, C Calder, C Linton, et al.Neuropharmacology|February 13, 2001
S 14506: novel receptor coupling at 5-HT(1A) receptorsG Milligan, E Kellett, C Dacquet, et al.British Journal of Pharmacology|September 28, 1999
Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPRD Smart, J C Jerman, S J Brough, et al.British Journal of Pharmacology|August 28, 1998
Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719D R Thomas, S A Gittins, L L Collin, et al.Molecular Psychiatry|January 19, 2011
Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restorationT M Eriksson, P Delagrange, M Spedding, et al.Neuropharmacology|April 19, 2003
Neuroprotective properties of tianeptine: interactions with cytokinesF Plaisant, M-A Dommergues, M Spedding, et al.Pageof 21